PH

	Researchers develop blood-brain-barrier-permeable nanoparticles for Alzheimer's disease treatment [23-08-2022] Alzheimer´s disease (AD) is a complex neurodegenerative disease that leads to insidious deterioration of brain functions. Current treatments for AD that focus on inhibition of amyloid beta (Aβ) aggregation failed to show effectiveness in people with AD symptoms.

Related News

	Nanobots Therapeutics successfully closes a Pre-Seed funding round of €478,000 [22-09-2023] Nanobiotechnology, Nanomedicine

	NBRAIN Neuroelectronics Announces FDA Breakthrough Device Designation for Its Graphene-Based Intelligent Network Modulation Platform [19-09-2023] Nanomedicine, Graphene

	Nanoneedle breakthrough gives hope for cheaper cancer treatment [24-08-2023] Nanomedicine, Nanotechnologies

	Nanovesicles from cells for biomedical applications [17-01-2023] Nanobiotechnology, Nanomedicine

	Wireless brain implant monitors neurotransmitters in real-time [16-01-2023] Nanomaterials, Nanobiotechnology, Nanomedicine

CLOSE

© Phantoms Foundation 2023